Dihydropyridine Calcium Channel Blocker class drugs

8 results

  • Azor

    (amlodipine besylate and olmesartan medoxomil)
    Daiichi Sankyo Inc.
    Usage: Azor is indicated for treating hypertension to lower blood pressure, either alone or with other antihypertensive agents. Effective blood pressure reduction reduces the risk of cardiovascular events such as strokes and heart attacks, with a focus on comprehensive cardiovascular risk management. Individual treatment plans should consider patient's specific risks.

  • Caduet

    (amlodipine besylate and atorvastatin calcium)
    Pfizer Laboratories Div Pfizer Inc
    Usage: CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.

  • Cleviprex

    (clevipidine)
    Chiesi USA, Inc.
    Usage: Cleviprex is indicated for lowering blood pressure in situations where oral medication is not feasible or desirable.

  • Katerzia

    (Amlodipine)
    Azurity Pharmaceuticals, Inc.
    Usage: KATERZIA is indicated for treating hypertension in adults and children (6 years and older) to reduce blood pressure and cardiovascular risks. It is also used for chronic stable angina, vasospastic angina, and to lower hospitalization risks in patients with confirmed coronary artery disease.

  • Norliqva

    (amlodipine)
    CMP Pharma, Inc.
    Usage: NORLIQVA® is indicated for treating hypertension in adults and children ages 6 and older, reducing cardiovascular event risk. It also treats chronic stable angina, vasospastic angina, and helps patients with angiographically documented coronary artery disease to lower hospitalization and revascularization risks. It can be used alone or with other agents.

  • Norvasc

    (amlodipine besylate)
    Viatris Specialty LLC
    Usage: NORVASC® is indicated for treating hypertension to lower blood pressure and reduce cardiovascular risks. Additionally, it is used for symptomatic treatment of chronic stable angina, vasospastic angina, and to reduce hospitalization and revascularization risks in patients with documented coronary artery disease.

  • Nymalize

    (nimodipine)
    Azurity Pharmaceuticals, Inc.
    Usage: NYMALIZE is indicated for improving neurological outcomes in adult patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms, by reducing the incidence and severity of ischemic deficits, irrespective of the patients' neurological condition post-ictus (Hunt and Hess Grades I-V).

  • Tribenzor

    (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide)
    Cosette Pharmaceuticals, Inc.
    Usage: Tribenzor is indicated for treating hypertension, either alone or with other antihypertensive agents, to lower blood pressure. This reduces the risk of cardiovascular events, such as strokes and myocardial infarctions. It is not intended for initial hypertension therapy and should be part of comprehensive cardiovascular risk management.